CymaBay Therapeutics, Inc.
CBAYDelisted Mar 22, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042074
CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.
Holders of 5% or more of CBAY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of CymaBay Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of CymaBay Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on CymaBay Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2023 | Perceptive Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Commodore Capital LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | TCG Crossover GP I, LLC | 13G/AOld format | – | – | – | SEC |
| Jul 8, 20224:57 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 14, 2022 | Boxer Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Commodore Capital LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Avoro Capital Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20225:08 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Nov 29, 2021 | TCG Crossover Management, LLC | 13GOld format | – | New | – | SEC |
| Jul 12, 2021 | Commodore Capital LP | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | D. E. Shaw & Co, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Foresite Capital Fund III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20219:57 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell CymaBay Therapeutics, Inc. shares.
No Form 144 notices for CymaBay Therapeutics, Inc. are on file.